Osmo just put real money—and serious industry muscle—behind the future of AI-driven scent.
The digital scent design company has closed a $70 million Series B, led by Two Sigma Ventures, bringing total funding to $130 million and signaling growing investor confidence in AI-powered olfaction as a core innovation engine for flavor and fragrance. New backers include Valor, Atreides, Amplo, Collab Fund, Lumina Partners, Alumni Ventures, and Stripe CEO Patrick Collison, alongside existing investors.
"Osmo is unlocking an entirely new sensory dimension for AI," said Colin Beirne, Partner at Two Sigma Ventures and new Osmo board observer. “Osmo proves this technology works commercially, democratizing access to custom fragrance development that was previously available only to brands spending millions. But fragrance is just the beginning. We're backing the infrastructure layer for digital olfaction, with applications spanning healthcare diagnostics to environmental monitoring."
The capital will fuel the scale-up of Osmo’s proprietary Olfactory Intelligence platform, which digitizes the entire fragrance lifecycle—from molecular discovery and formula creation through manufacturing and packaging. For F&F players, the promise is concrete: faster time-to-market, lower development costs, and access to entirely new ingredient families discovered through AI screening of billions of molecules before synthesis ever begins. Osmo says its approach delivers 10x higher success rates and 5–10x greater cost efficiency than traditional discovery models.
Osmo is also building for execution. The company unveiled a heavyweight executive team drawn directly from the industry: Mike Rytokoski (ex-Amyris, Unilever, Clorox) as Chief Commercial Officer, Mateusz Brzuchacz (ex-Givaudan, IFF, Phoenix F&F) as Chief Operating Officer, and Nate Pearson (ex-Tesla) as CFO. Former dsm-firmenich executive Boet Brinkgreve joins the board, reinforcing Osmo’s ambition to work at global-industry scale.
The timing matters. Osmo reports that in 2025 its AI-first platform reportedly generated more published fragrance ingredient patents than all major industry players combined, at a moment when traditional discovery pipelines are slowing and many incumbents are, per the company, publishing few—or zero—new ingredient patents.
"Osmo’s Olfactory Intelligence is optimized for speed, novelty, and accuracy, where prediction drives synthesis, not the other way around," said Ben Amorelli, Director of Chemistry at Osmo. "We’re not just finding individual molecules, we’re discovering entirely new ingredient families. While a traditional patent might cover one or two molecules, ours can include 50 to 250 new molecules built around novel core structures that have never been explored in fragrance."
Beyond fragrance, Osmo is already extending Olfactory Intelligence into non-animal safety testing, healthcare diagnostics, environmental monitoring, and public safety, including a landmark AI-driven skin irritation study published in Alternatives to Laboratory Animals.
